Institute MECHNIKOV, created as part of the Russian and Nicaraguan project in Managua, began production of commercial batches of influenza vaccine. April 10. Managua. Institute MECHNIKOV has launched the production of a commercial vaccine batches in Managua (Nicaragua). The launch of the production lines was attended by the advisor for investments of the Government of
venezuelan-ministry-of-health
As part of the official visit to Venezuela of the Russian Deputy Prime Minister for Defense Industry Mr. Dmitry Rogozin, the Director of SPbSRIVS of the Russian Federal Biomedical Agency Mr. Victor Trukhin and the Minister of Health of Venezuela Ms. Luisana Melo signed a memo of understanding providing for an assessment of the cooperation
Tagged under: ,

Vaccine factory (video of Channel 5)

September 30, 2016, a meeting of the co-chairs of the Intergovernmental Russian-Nicaraguan Commission on Trade, Economic, Scientific, and Technology Cooperation was held in Moscow. Deputy Director of SPbSRIVS, Mr. Andrey Vasiliev, presented a new project envisaging a new pharmaceutical facility in Managua, Nicaragua, to synthesize influenza vaccines using an imported Russian active component, under development
cleanroom
In Managua, engineers of the joint Russian-Nicaraguan vaccine company Mechnikov S.A. began the installation of the cleanroom facility. All necessary materials were flown to the capital of Nicaragua on cargo flights from St. Petersburg. “Almost 100 tons of equipment and materials for the various cleanrooms were shipped to Managua by air freight. Although this was
ambassadors
The ambassadors of the CAIS countries, through the Ambassador of Honduras, Eleonor Ortes Williams, expressed sincere gratitude for the high level of organization and holding of the meeting with the leadership of SPbSRIVS and Mechnikov S.A., held during the St. Petersburg Economic Forum on the site of SPbSRIVS in Krasnoye Selo. In her letter to
cais
At the anniversary St. Petersburg International Economic Forum, the ambassadors of the Central American Integration System (CAIS) nations visited the St. Petersburg Research Institute of Vaccines and Serums (SPbSRIVS) of the Russian Federal Biomedical Agency. The purpose of the visit was to become acquainted with the leading Russian manufacturer of vaccines for the prevention of
construction
The second and final cash tranche of about $ 10 million has been sent by the Russian Federation to Nicaragua, where the FMBA of Russia and the specialized institution of the department – SPbSRIVS, together with the Nicaraguan Institute for Social Development, is implementing a project to build modern pharmaceutical production of vaccines and a